DIN 02471027 — XIIDRA 5 %
XIIDRA is a solution of Lifitegrast marketed by BAUSCH & LOMB INC. The full Lifitegrast monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02471027
- Brand name
- XIIDRA
- Active ingredient
- Lifitegrast
- Strength
- 5 %
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Manufacturer
- BAUSCH & LOMB INC
- Health Canada status
- MARKETED
- Drug class
- Lymphocyte function-associated antigen-1 (LFA-1) antagonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.